EvoAir Holdings Inc. (EVOH) News
Follow EvoAir Holdings Inc. (EVOH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
EvoAir Holdings Reports FY 2026 Revenue of $319,052
Revenue rose 12.1% from $284,666 a year earlier. Net loss narrowed to $4.09 million from $14.63 million; diluted loss per share was $(0.15) versus $(0.55) in FY 2025.
EARNINGS | Oct 14, 2026, 01:35 PM UTC
H
Opening Day: Scribe Therapeutics makes strong trading debut
Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the market with cardiometabolic programs at the forefront and early momentum beh
MNA | Jul 27, 2026, 03:21 PM UTC